AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2023
Feb 3, 2023
29745_dirs_2023-02-03_ecff694f-2b3d-4c3a-8bd3-649ad5e87594.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-02-01
Reporting Person: Jonsson Patrik (EVP&Pres, LLY Imm, LLY USA&CCO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-01 | Common Stock | M | 6690 | — | Acquired | 38052 | Direct |
| 2023-02-01 | Common Stock | F | 2997 | $344.15 | Disposed | 35055 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-01 | Restricted Stock Unit | $ | M | 6690 | Disposed | 2023-02-01 | Common Stock (6690.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 469 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29